- Home
- NATH vs SVRA Comparison
NATH vs SVRA Comparison
Compare NATH & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATH
- SVRA
- Stock Information
- Founded
- NATH 1916
- SVRA 2007
- Country
- NATH United States
- SVRA United States
- Employees
- NATH N/A
- SVRA N/A
- Industry
- NATH Restaurants
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- NATH Consumer Discretionary
- SVRA Health Care
- Exchange
- NATH Nasdaq
- SVRA Nasdaq
- Market Cap
- NATH 442.2M
- SVRA 527.2M
- IPO Year
- NATH N/A
- SVRA N/A
- Fundamental
- Price
- NATH $105.16
- SVRA $4.41
- Analyst Decision
- NATH
- SVRA Buy
- Analyst Count
- NATH 0
- SVRA 8
- Target Price
- NATH N/A
- SVRA $6.88
- AVG Volume (30 Days)
- NATH 39.4K
- SVRA 1.3M
- Earning Date
- NATH 11-07-2025
- SVRA 11-13-2025
- Dividend Yield
- NATH 1.90%
- SVRA N/A
- EPS Growth
- NATH 9.62
- SVRA N/A
- EPS
- NATH 5.77
- SVRA N/A
- Revenue
- NATH $150,413,000.00
- SVRA N/A
- Revenue This Year
- NATH N/A
- SVRA N/A
- Revenue Next Year
- NATH N/A
- SVRA N/A
- P/E Ratio
- NATH $18.45
- SVRA N/A
- Revenue Growth
- NATH 6.38
- SVRA N/A
- 52 Week Low
- NATH $75.15
- SVRA $1.89
- 52 Week High
- NATH $118.50
- SVRA $4.48
- Technical
- Relative Strength Index (RSI)
- NATH 42.78
- SVRA 80.22
- Support Level
- NATH $106.26
- SVRA $3.50
- Resistance Level
- NATH $109.98
- SVRA $4.48
- Average True Range (ATR)
- NATH 2.50
- SVRA 0.20
- MACD
- NATH -0.44
- SVRA 0.08
- Stochastic Oscillator
- NATH 22.33
- SVRA 93.81
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.